Search Results - "Viennot, Stephanie"
-
1
Gastrointestinal bleeding of undetermined origin: What diagnostic strategy to propose?
Published in Journal of visceral surgery (01-08-2023)“…Gastrointestinal bleeding of undetermined origin (GBUO) is defined as gastrointestinal bleeding without an identified cause or location despite an endoscopic…”
Get full text
Journal Article -
2
Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients
Published in Alimentary pharmacology & therapeutics (01-04-2020)“…Summary Background The management of Crohn's disease patients with perianal lesions and anti‐TNF failure is challenging. Aims To assess the effectiveness of…”
Get full text
Journal Article -
3
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
Published in Digestive and liver disease (01-03-2020)“…Phase III trials demonstrated effectiveness of tofacitinib, an oral Janus kinase inhibitor, to induce and maintain remission in patients with…”
Get full text
Journal Article -
4
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained Remission
Published in Clinical gastroenterology and hepatology (01-02-2018)“…Little is known about long-term outcomes of patients with Crohn’s disease (CD) after infliximab withdrawal. We aimed to describe the long-term outcomes of…”
Get full text
Journal Article Web Resource -
5
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study
Published in Alimentary Pharmacology & Therapeutics (Suppl) (01-02-2021)“…Summary Background The prevalence of inflammatory bowel diseases (IBD) is high in women of childbearing age. Achieving clinical remission from conception to…”
Get full text
Journal Article -
6
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study
Published in Inflammatory bowel diseases (03-04-2023)“…Owing to growing number of therapeutic options with similar efficacy and safety, we compared the acceptability of therapeutic maintenance regimens in…”
Get full text
Journal Article -
7
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
Published in BMC gastroenterology (01-12-2022)“…No study has performed a face-to-face comparison of biologics after the failure of the first anti-TNF agent in patients with Crohn's disease (CD). The aim of…”
Get full text
Journal Article -
8
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort
Published in Alimentary Pharmacology & Therapeutics (Suppl) (01-08-2021)“…Summary Background Up to 25% of patients with ulcerative colitis (UC) will require hospitalization for severe flare. In patients hospitalised for severe flare,…”
Get full text
Journal Article -
9
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID
Published in The American journal of gastroenterology (01-11-2020)“…New therapeutic options for patients with Crohn's disease (CD) with perianal lesions failing anti-tumor necrosis factor (TNF) agents are needed. We aimed to…”
Get full text
Journal Article -
10
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease
Published in Clinical gastroenterology and hepatology (01-03-2020)“…Few data are available on the effects of tumor necrosis factor (TNF) antagonist therapy for patients with internal fistulizing Crohn’s disease (CD) and there…”
Get full text
Journal Article -
11
Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study
Published in Scandinavian journal of gastroenterology (02-12-2022)“…There are currently no comparative data on the efficacy and safety of vedolizumab and ustekinumab in ulcerative colitis (UC) after anti-TNF therapy fails. We…”
Get full text
Journal Article -
12
A Scoring System to Determine Patients’ Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative Colitis
Published in Clinical gastroenterology and hepatology (01-08-2021)“…There is consensus on the criteria used to define acute severe ulcerative colitis (ASUC) and on patient management, but it has been a challenge to identify…”
Get full text
Journal Article -
13
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID
Published in Inflammatory bowel diseases (01-08-2022)“…Abstract Background The prevalence of obesity and the number of bariatric surgeries in both the general population and in patients with inflammatory bowel…”
Get full text
Journal Article Web Resource -
14
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis
Published in Clinical gastroenterology and hepatology (01-03-2020)“…It is a challenge to manage patients with ulcerative proctitis (UP) refractory to standard therapy. We investigated the effectiveness of tumor necrosis factor…”
Get full text
Journal Article Web Resource -
15
-
16
Pleural ultrasound compared with chest radiographic detection of pneumothorax resolution after drainage
Published in Chest (01-09-2010)“…Pleural ultrasonography (PU) is more sensitive than chest radiograph (CXR) for diagnosing pneumothorax and could be useful for detecting resolution of…”
Get more information
Journal Article -
17
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study
Published in Digestive and liver disease (01-11-2020)“…There are few data concerning patients with Crohn's disease (CD) complicated by a stricture of the upper gastrointestinal tract (UGT). We evaluated the outcome…”
Get full text
Journal Article Web Resource -
18
Anti‐TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)
Published in Alimentary Pharmacology & Therapeutics (Suppl) (01-10-2018)“…Summary Background Genital fistulas represent a devastating complication of Crohn's disease. Only studies with small sample sizes have evaluated the efficacy…”
Get full text
Journal Article -
19
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study
Published in Infection prevention in practice (01-03-2023)“…Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is…”
Get full text
Journal Article Web Resource -
20
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID
Published in The American journal of gastroenterology (01-09-2022)“…INTRODUCTION: The objective of this study was to describe the efficacy and safety of infliximab (IFX) reintroduction in Crohn's disease (CD) after stopping for…”
Get full text
Journal Article